US Stock MarketDetailed Quotes

LUMO Lumos Pharma

Watchlist
  • 4.380
  • +0.080+1.86%
Close Dec 2 16:00 ET
  • 4.380
  • 0.0000.00%
Post 20:01 ET
37.88MMarket Cap-1023P/E (TTM)

About Lumos Pharma Company

Lumos Pharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for rare diseases. Its product includes LUM-201, an oral growth hormone stimulating small molecule for the treatment of pediatric growth hormone deficiency (PGHD). The company was founded on June 4, 1999 and is headquartered in Austin, TX.

Company Profile

SymbolLUMO
Company NameLumos Pharma
Listing DateNov 11, 2011
Issue Price7.00
Founded1999
CEOMr. Richard J. Hawkins
MarketNASDAQ
Employees33
Fiscal Year Ends12-31
Address4200 Marathon Boulevard,Suite 200
CityAustin
ProvinceTexas
CountryUnited States of America
Zip Code78756
Phone1-512-215-2630
Websitehttp://www.lumos-pharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Richard J. Hawkins
  • Chairman of the Board and Chief Executive Officer
  • 952.87K
  • Lori Lawley
  • Chief Financial Officer, Secretary and Principal Accounting Officer
  • 569.78K
  • Dr. John C. McKew, PhD
  • President and Chief Scientific Officer
  • 904.79K
  • Dr. Thomas A. Raffin, M.D.
  • Lead Independent Director
  • 86.83K
  • Dr. Joseph S. McCracken, D.V.M.
  • Independent Director
  • 56.33K
  • Lota S. Zoth, C.P.A.
  • Independent Director
  • 69.33K
  • Kevin M. Lalande
  • Independent Director
  • 54.33K
  • Chad A. Johnson, J.D.
  • Independent Director
  • 64.33K
  • Dr. An van Es-Johansson, M.D.
  • Independent Director
  • 52.83K
  • Bradley J. Powers
  • General Counsel
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data